CSIMarket
 


Longeveron Inc   (LGVN)
Other Ticker:  
 
 

LGVN's Income from Cont. Operations Growth by Quarter and Year

Longeveron Inc 's Income from Cont. Operations results by quarter and year




LGVN Income from Cont. Operations (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 9.87 0.00 0.00
III Quarter September -5.24 -4.86 0.00 0.00
II Quarter June -5.62 -5.01 0.00 0.00
I Quarter March -3.51 0.00 0.00 0.00
FY   -14.37 0.00 0.00 0.00



LGVN Income from Cont. Operations third quarter 2022 Y/Y Growth Comment
Longeveron Inc in the third quarter 2022 recorded loss from continued operations of $ -5.24 millions.

According to the results reported in the third quarter 2022, Longeveron Inc achieved the best Income from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Longeveron Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2022.




LGVN Income from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Longeveron Inc 's third quarter 2022 Income from Cont. Operations $ -5.24 millions LGVN's Income Statement
Longeveron Inc 's third quarter 2021 Income from Cont. Operations $ -4.86 millions Quarterly LGVN's Income Statement
New: More LGVN's historic Income from Cont. Operations Growth >>


LGVN Income from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Longeveron Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LGVN's III. Quarter Q/Q Income from Cont. Operations Comment
Despite the fact, that Longeveron Inc in the III. Quarter 2022 showed loss from continued operations of $ -5.24 millions, management mentioned, that those numbers point to improvement compare to the -5.62 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Longeveron Inc achieved highest sequential Income from Cont. Operations growth. While Longeveron Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LGVN's III. Quarter Q/Q Income from Cont. Operations Comment
Although Longeveron Inc in the III. Quarter 2022 showed loss from continued operations of $ -5.24 millions, it should be point out, that current results point to improvement in contrast to the -5.62 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Longeveron Inc achieved highest sequential Income from Cont. Operations growth. While Longeveron Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Longeveron Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Income from Cont. Operations 12 Months Ending $ -4.51 $ -4.12 $ -3.51 $ 0.00 $ 0.00
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
Longeveron Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -5 millions in the Sep 30 2022 period.
The results are detiriorating as the cumulative loss from continued operations is inflating from $ -4.12 millions in the twelve months ending a quarter before and $ millions for the twelve months ending in the quarter Sep 30 2021.

Longeveron Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
Longeveron Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -5 millions in the Sep 30 2022 period.
The situation is worsening as the cumulative loss from continued operations is inflating from $ -4.12 millions in TTM ending quarter Jun 30 2022 and $ millions for the twelve months ending in the quarter Sep 30 2021.

Longeveron Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
LGVN's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for LGVN's Competitors
Income from Cont. Operations Growth for Longeveron Inc 's Suppliers
Income from Cont. Operations Growth for LGVN's Customers

You may also want to know
LGVN's Annual Growth Rates LGVN's Profitability Ratios LGVN's Asset Turnover Ratio LGVN's Dividend Growth
LGVN's Roe LGVN's Valuation Ratios LGVN's Financial Strength Ratios LGVN's Dividend Payout Ratio
LGVN's Roa LGVN's Inventory Turnover Ratio LGVN's Growth Rates LGVN's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2022
Amgen Inc 13.75%$ 13.747 millions
Viatris Inc 13.74%$ 13.740 millions
Corcept Therapeutics Inc13.39%$ 13.386 millions
Prestige Consumer Healthcare Inc 12.06%$ 12.063 millions
Assertio Holdings inc 11.69%$ 11.694 millions
Syneos Health Inc 11.25%$ 11.255 millions
Option Care Health Inc 9.43%$ 9.435 millions
Vertex Pharmaceuticals Inc9.22%$ 9.223 millions
Iqvia Holdings Inc 8.43%$ 8.429 millions
Mettler toledo International Inc 8.30%$ 8.301 millions
Acadia Healthcare Company Inc 7.58%$ 7.579 millions
Atrion Corporation6.79%$ 6.790 millions
Avantor Inc 6.51%$ 6.505 millions
American Oncology Network Inc 4.64%$ 4.639 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com